|
|
| | L-Arginine, L-seryl-L-threonyl-L-leucyl-L-prolyl-L-α-glutamyl-L-threonyl-L-threonyl-L-valyl-L-valyl-L-arginyl- Basic information |
| | L-Arginine, L-seryl-L-threonyl-L-leucyl-L-prolyl-L-α-glutamyl-L-threonyl-L-threonyl-L-valyl-L-valyl-L-arginyl- Chemical Properties |
| density | 1.49±0.1 g/cm3(Predicted) | | pka | 3.31±0.10(Predicted) |
| | L-Arginine, L-seryl-L-threonyl-L-leucyl-L-prolyl-L-α-glutamyl-L-threonyl-L-threonyl-L-valyl-L-valyl-L-arginyl- Usage And Synthesis |
| Uses | HBV Seq1 aa:141-151 is a peptide. HBV Seq1 aa:141-151 can be used for the research of chronic hepatitis B virus (HBV) [1]. | | References | [1] A J Sijts, et al. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J Exp Med. 2000 Feb 7;191(3):503-14. DOI:10.1084/jem.191.3.503 |
| | L-Arginine, L-seryl-L-threonyl-L-leucyl-L-prolyl-L-α-glutamyl-L-threonyl-L-threonyl-L-valyl-L-valyl-L-arginyl- Preparation Products And Raw materials |
|